ICON PLC (ICLR): Price and Financial Metrics
GET POWR RATINGS... FREE!
ICLR POWR Grades
- ICLR scores best on the Growth dimension, with a Growth rank ahead of 91.55% of US stocks.
- The strongest trend for ICLR is in Growth, which has been heading up over the past 179 days.
- ICLR's current lowest rank is in the Quality metric (where it is better than 33.04% of US stocks).
ICLR Stock Summary
- With a market capitalization of $18,339,717,900, ICON PLC has a greater market value than 89.22% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, ICON PLC is reporting a growth rate of 108.3%; that's higher than 86.18% of US stocks.
- As for revenue growth, note that ICLR's revenue has grown 75.95% over the past 12 months; that beats the revenue growth of 88.62% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to ICON PLC are FWONA, DRI, LBRDA, MOS, and CACC.
- Visit ICLR's SEC page to see the company's official filings. To visit the company's web site, go to www.iconplc.com.
ICLR Valuation Summary
- In comparison to the median Healthcare stock, ICLR's EV/EBIT ratio is 447.37% higher, now standing at 41.6.
- ICLR's price/sales ratio has moved up 0.4 over the prior 243 months.
Below are key valuation metrics over time for ICLR.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ICLR | 2022-11-01 | 2.1 | 2.0 | 76.3 | 41.6 |
| ICLR | 2022-10-31 | 2.1 | 2.0 | 76.8 | 41.8 |
| ICLR | 2022-10-28 | 2.1 | 2.0 | 77.4 | 42.1 |
| ICLR | 2022-10-27 | 2.1 | 1.9 | 74.5 | 40.8 |
| ICLR | 2022-10-26 | 2.1 | 2.0 | 76.8 | 41.8 |
| ICLR | 2022-10-25 | 2.1 | 2.0 | 76.4 | 41.6 |
ICLR Growth Metrics
- Its 3 year revenue growth rate is now at 146.16%.
- The 5 year net cashflow from operations growth rate now stands at 77.72%.
- The 4 year revenue growth rate now stands at 70.78%.
The table below shows ICLR's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-06-30 | 7,588.43 | 997.754 | 209.902 |
| 2022-06-30 | 7,588.43 | 997.754 | 209.902 |
| 2022-03-31 | 6,524.392 | 944.138 | 168.033 |
| 2022-03-31 | 6,524.392 | 944.138 | 168.033 |
| 2021-12-31 | 5,480.826 | 829.142 | 153.185 |
| 2021-09-30 | 4,355.934 | 734.746 | 177.951 |
ICLR's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ICLR has a Quality Grade of B, ranking ahead of 84.72% of graded US stocks.
- ICLR's asset turnover comes in at 0.882 -- ranking 150th of 561 Business Services stocks.
- 500 - Internal server error
The table below shows ICLR's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2020-12-31 | 0.882 | 0.292 | 0.489 |
| 2019-12-31 | 1.067 | 0.296 | 0.542 |
| 2018-12-31 | 1.153 | 0.300 | 0.447 |
| 2017-12-31 | 0.885 | 0.416 | 0.420 |
| 2016-12-31 | 0.940 | 0.423 | 0.403 |
| 2015-12-31 | 0.970 | 0.423 | 0.516 |
ICLR Price Target
For more insight on analysts targets of ICLR, see our ICLR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $205.14 | Average Broker Recommendation | 1.72 (Moderate Buy) |
ICLR Stock Price Chart Interactive Chart >
ICLR Price/Volume Stats
| Current price | $219.00 | 52-week high | $313.00 |
| Prev. close | $217.26 | 52-week low | $171.43 |
| Day low | $215.76 | Volume | 173,600 |
| Day high | $219.95 | Avg. volume | 567,733 |
| 50-day MA | $196.14 | Dividend yield | N/A |
| 200-day MA | $218.90 | Market Cap | 17.82B |
ICON PLC (ICLR) Company Bio
ICON Public Limited Company provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company was founded in 1990 and is based in Dublin, Ireland.
Latest ICLR News From Around the Web
Below are the latest news stories about ICON PLC that investors may wish to consider to help them evaluate ICLR as an investment opportunity.
ICON plc to Present at the 2022 Evercore ISI HealthCONx ConferenceDUBLIN, November 23, 2022--ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference |
‘The next four weeks will be better’: Jim Cramer sees reasons to be more positive on stocks and gives these 2 names his stamp of approvalUnhappy with the state of the portfolio after miserable 2022 stock market action? You are probably far from alone. Most investors have struggled to make headway in this year’s ongoing bear market, which has provided only short periods of relief. That said, with the year’s end getting ever nearer, Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program, thinks the bears are showing signs of exhaustion and this spells good news for battered investors. |
ICON upgraded to buy at BofA on core growth, deal synergiesBofA Securities has upgraded contract research organization ICON plc (ICON) to buy from neutral citing the integration of PRA Health Sciences and confidence in core growth. |
ICON Public Limited Company (ICLR) Q3 2022 Earnings Call TranscriptICON Public Limited Company (NASDAQ:NASDAQ:ICLR) Q3 2022 Earnings Conference Call November 03, 2022 08:00 AM ET Company Participants Kate Haven - Vice President of Investor Relations… |
ICON Public Limited Company 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:ICLR)The following slide deck was published by ICON Public Limited Company in conjunction with their 2022 Q3 earnings call. |
ICLR Price Returns
| 1-mo | 14.19% |
| 3-mo | 2.60% |
| 6-mo | N/A |
| 1-year | -19.49% |
| 3-year | 33.90% |
| 5-year | 87.98% |
| YTD | -29.29% |
| 2021 | 58.84% |
| 2020 | 13.21% |
| 2019 | 33.29% |
| 2018 | 15.21% |
| 2017 | 49.14% |
Loading social stream, please wait...